SCHEMBL31159907

SCHEMBL31159907

Cn1cnc2c(OC(F)F)cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PIK3CB P42338 2/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CG P48736 1/20 0.39
DDB1 Q16531 2/20 0.36
CRBN Q96SW2 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GLA P06280 1/20 0.36
TSHR P16473 1/20 0.36
DPP4 P27487 1/20 0.35
KCNH2 Q12809 1/20 0.35
BACE1 P56817 8/20 0.34
APP P05067 1/20 0.33
CTSD P07339 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
RHEB Q15382 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7853887 0.80 TLR8 (0.42) GAAMAPTDDB1CRBNKDM4E
SCHEMBL27249581 0.77 ALDH1A1 (0.43) GAAMAPTPIK3CBDDB1CRBN
SCHEMBL26447071 0.76 DPP4 (0.38) GAAMAPTDDB1CRBNKDM4E
SCHEMBL27249585 0.73 LMNA (0.39) MAPTSMN1; SMN2DDB1CRBNDPP4
SCHEMBL27249583 0.73 DPP4 (0.43) GAAMAPTSMN1; SMN2PIK3CBPIK3CD
SCHEMBL23022464 0.72 DDB1 (0.41) GAADDB1CRBNKDM4EALDH1A1
SCHEMBL19848258 0.72 DDB1 (0.41) GAADDB1CRBNKDM4EALDH1A1
SCHEMBL30976952 0.72 CTSS (0.36) BACE1
SCHEMBL29435809 0.72 DDB1 (0.41) GAADDB1CRBNKDM4EALDH1A1
SCHEMBL31140536 0.71 RAB9A (0.35) KDM4EBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688144-A1 COMPOUNDS AS GLP-1R AGONISTS Terns Pharmaceuticals, Inc. (US) 2026-02-11 EP disclosed
WO-2024206878-A1 COMPOUNDS AS GLP-1R AGONISTS TERNS PHARMACEUTICALS, INC. (US) 2024-10-03 WO disclosed